Direkt zum Inhalt

Entries of Wirtz, Ralph M. on the publication server

Up a level
Export as
[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item type | No Grouping
Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013
Number of items: 27.

2024

Wolff, Ingmar, Kravchuk, Anton P., Wirtz, Ralph M., Schlomm, Thorsten, Rabien, Anja, Rong, Dezhi, Hofbauer, Sebastian L., Labonté, Flora K., Barski, Dimitri, Otto, Thomas, Gössl, Andreas, Brookman‐May, Sabine D., Gilfrich, Christian P., Ecke, Thorsten H. and May, Matthias (2024) Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial. BJU International 134 (6), pp. 992-1000. Fulltext not available.

Haas, Maximilian , Kriegmair, Maximilian C., Breyer, Johannes , Sikic, Danijel, Wezel, Felix, Roghmann, Florian, Brehmer, Mirco, Wirtz, Ralph M., Jarczyk, Jonas, Erben, Philipp, Bahlinger, Veronika, Goldschmidt, Franziska, Fechner, Guido, Chen, Jack, Paxinos, Ellen, Bates, Michael, Zengerling, Friedemann, Bolenz, Christian, Burger, Maximilian, Hartmann, Arndt and Eckstein, Markus (2024) Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor. BJU International.

2023

Breyer, Johannes, Eckstein, Markus, Sikic, Danijel, Wezel, Felix, Roghmann, Florian, Brehmer, Mirco, Wirtz, Ralph M., Jarczyk, Jonas, Erben, Philipp, Bahlinger, Veronika, Goldschmidt, Franziska, Fechner, Guido, Chen, Jack, Paxinos, Ellen, Bates, Michael, Haas, Maximilian, Zengerling, Friedemann, Bolenz, Christian, Burger, Maximilian, Hartmann, Arndt, Kriegmair, Maximilian C. and BRIDGE Consortium e.V., . (2023) Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial). Scientific Reports 13 (1).

Klümper, Niklas, Wüst, Lennert, Saal, Jonas, Ralser, Damian J., Zarbl, Romina, Jarczyk, Jonas, Breyer, Johannes, Sikic, Danijel, Wullich, Bernd, Bolenz, Christian, Roghmann, Florian, Hölzel, Michael, Ritter, Manuel, Strieth, Sebastian, Hartmann, Arndt, Erben, Philipp, Wirtz, Ralph M., Landsberg, Jennifer, Dietrich, Dimo and Eckstein, Markus (2023) PD-L1 ( CD274 ) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma. OncoImmunology 12 (1). Fulltext not available.

Klümper, Niklas, Wüst, Lennert, Saal, Jonas, Ralser, Damian J., Zarbl, Romina, Jarczyk, Jonas, Breyer, Johannes, Sikic, Danijel, Wullich, Bernd, Bolenz, Christian, Roghmann, Florian, Hölzel, Michael, Ritter, Manuel, Strieth, Sebastian, Hartmann, Arndt, Erben, Philipp, Wirtz, Ralph M., Landsberg, Jennifer, Dietrich, Dimo and Eckstein, Markus (2023) PD-L1 ( CD274 ) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma. OncoImmunology 12 (1). Fulltext not available.

Erlmeier, Franziska, Klümper, Niklas, Landgraf, Laura, Strissel, Pamela L., Strick, Reiner, Sikic, Danijel, Taubert, Helge, Wach, Sven, Geppert, Carol I., Bahlinger, Veronika, Breyer, Johannes, Ritter, Manuel, Bolenz, Christian, Roghmann, Florian, Erben, Philipp, Schwamborn, Kristina, Wirtz, Ralph M., Horn, Thomas, Wullich, Bernd, Hölzel, Michael, Hartmann, Arndt, Gschwend, Jürgen E., Weichert, Wilko and Eckstein, Markus (2023) Spatial Immunephenotypes of Distant Metastases but not Matched Primary Urothelial Carcinomas Predict Response to Immune Checkpoint Inhibition. European Urology 83 (2), pp. 133-142. Fulltext not available.

2022

Bubb, Maria, Beyer, Anna-Sophia Lieselott, Dasgupta, Pooja , Kaemmerer, Daniel, Sänger, Jörg, Evert, Katja, Wirtz, Ralph M., Schulz, Stefan and Lupp, Amelie (2022) Assessment of G Protein-Coupled Oestrogen Receptor Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody. International Journal of Molecular Sciences 23 (9), p. 5191. Fulltext not available.

Sikic, Danijel, Eckstein, Markus, Weyerer, Veronika, Kubon, Jennifer, Breyer, Johannes, Roghmann, Florian, Kunath, Frank, Keck, Bastian, Erben, Philipp, Hartmann, Arndt, Wirtz, Ralph M., Wullich, Bernd, Taubert, Helge and Wach, Sven (2022) High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations 40 (2), 63.e9-63.e18. Fulltext not available.

Klümper, Niklas, Ralser, Damian J., Ellinger, Jörg , Roghmann, Florian, Albrecht, Julia , Below, Eduard , Alajati, Abdullah, Sikic, Danijel, Breyer, Johannes, Bolenz, Christian, Zengerling, Friedemann, Erben, Philipp, Schwamborn, Kristina, Wirtz, Ralph M., Horn, Thomas, Nagy, Dora, Toma, Marieta, Kristiansen, Glen, Büttner, Thomas, Hahn, Oliver, Grünwald, Viktor, Darr, Christopher, Erne, Eva, Rausch, Steffen, Bedke, Jens , Schlack, Katrin, Abbas, Mahmoud, Zschäbitz, Stefanie, Schwab, Constantin, Mustea, Alexander, Adam, Patrick, Manseck, Andreas, Wullich, Bernd, Ritter, Manuel, Hartmann, Arndt, Gschwend, Jürgen, Weichert, Wilko, Erlmeier, Franziska, Hölzel, Michael and Eckstein, Markus (2022) Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance. Clinical Cancer Research 29 (8), pp. 1496-1505. Fulltext not available.

Mayr, Roman, Eckstein, Markus, Wirtz, Ralph M., Santiago-Walker, Ademi, Baig, Mahadi, Sundaram, Ramesh, Carcione, Jenna Cody , Stoehr, Robert, Hartmann, Arndt, Bolenz, Christian, Burger, Maximilian, Otto, Wolfgang, Erben, Philipp and Breyer, Johannes (2022) Prognostic and Predictive Value of Fibroblast Growth Factor Receptor Alterations in High-grade Non–muscle-invasive Bladder Cancer Treated with and Without Bacillus Calmette-Guérin Immunotherapy. European Urology 81 (6), pp. 606-614. Fulltext not available.

2021

Sikic, Danijel, Taubert, Helge , Wirtz, Ralph M., Breyer, Johannes, Eckstein, Markus, Weyerer, Veronika , Kubon, Jennifer, Erben, Philipp , Bolenz, Christian, Burger, Maximilian, Hartmann, Arndt, Wullich, Bernd, Wach, Sven and Keck, Bastian (2021) High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer. Life 11 (7), p. 642. Fulltext not available.

Tully, Karl H., Jütte, Hendrik, Wirtz, Ralph M., Jarczyk, Jonas, Santiago-Walker, Ademi, Zengerling, Friedemann, Breyer, Johannes, Sikic, Danijel, Kriegmair, Maximilian C., von Hardenberg, Jost , Wullich, Bernd, Taubert, Helge, Weyerer, Veronika, Stoehr, Robert, Bolenz, Christian, Burger, Maximilian, Porubsky, Stefan , Hartmann, Arndt, Roghmann, Florian, Erben, Philipp and Eckstein, Markus (2021) Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy. Urology 157, pp. 93-101. Fulltext not available.

2020

Sikic, Danijel, Eckstein, Markus, Wirtz, Ralph M., Jarczyk, Jonas, Worst, Thomas S. , Porubsky, Stefan , Keck, Bastian, Kunath, Frank, Weyerer, Veronika, Breyer, Johannes , Otto, Wolfgang, Rinaldetti, Sebastien, Bolenz, Christian, Hartmann, Arndt, Wullich, Bernd and Erben, Philipp (2020) FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy. Journal of Clinical Medicine 9 (4), p. 994. Fulltext not available.

2019

Erben, Philipp, Sikic, Danijel, Wirtz, Ralph M., Martini, Thomas, Weis, Cleo-Aron, Breyer, Johannes, Otto, Wolfgang, Keck, Bastian, Hartmann, Arndt and Bolenz, Christian (2019) Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder. Virchows Archiv 474 (2), pp. 209-217. Fulltext not available.

Sikic, Danijel, Wirtz, Ralph M., Wach, Sven, Dyrskjøt, Lars , Erben, Philipp, Bolenz, Christian, Breyer, Johannes, Otto, Wolfgang, Hoadley, Katherine A. , Lerner, Seth P., Eckstein, Markus, Hartmann, Arndt and Keck, Bastian (2019) Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts. Translational Oncology 12 (4), pp. 661-668. Fulltext not available.

Eckstein, Markus, Erben, Philipp, Kriegmair, Maximilian C., Worst, Thomas S., Weiß, Cleo-Aron, Wirtz, Ralph M., Wach, Sven, Stoehr, Robert, Sikic, Danijel, Geppert, Carol I., Weyerer, Veronika, Bertz, Simone, Breyer, Johannes, Otto, Wolfgang, Keck, Bastian, Burger, Maximilian, Taubert, Helge, Weichert, Wilko, Wullich, Bernd, Bolenz, Christian, Hartmann, Arndt and Erlmeier, Franziska (2019) Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab. European Journal of Cancer 106, pp. 234-243. Fulltext not available.

Pfannstiel, Carolin, Strissel, Pamela L., Chiappinelli, Katherine B., Sikic, Danijel, Wach, Sven, Wirtz, Ralph M., Wullweber, Adrian, Taubert, Helge, Breyer, Johannes, Otto, Wolfgang, Worst, Thomas, Burger, Maximilian, Wullich, Bernd, Bolenz, Christian, Fuhrich, Nicole, Geppert, Carol I., Weyerer, Veronika, Stoehr, Robert, Bertz, Simone, Keck, Bastian, Erlmeier, Franziska, Erben, Philipp, Hartmann, Arndt, Strick, Reiner and Eckstein, Markus (2019) The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes. Cancer Immunology Research 7 (6), pp. 923-938. Fulltext not available.

2018

Worst, Thomas S., Weis, Cleo-Aron, Stöhr, Robert, Bertz, Simone, Eckstein, Markus, Otto, Wolfgang, Breyer, Johannes, Hartmann, Arndt, Bolenz, Christian, Wirtz, Ralph M. and Erben, Philipp (2018) CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making. Scientific Reports 8 (1). Fulltext not available.

Breyer, Johannes, Wirtz, Ralph M., Erben, Philipp, Rinaldetti, Sebastien, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Sikic, Danijel, Denzinger, Stefan, Burger, Maximilian, Hartmann, Arndt and Otto, Wolfgang (2018) FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer. BJU International 123 (1), pp. 187-196. Fulltext not available.

Breyer, Johannes, Wirtz, Ralph M., Erben, Philipp, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Bertz, Simone, Sikic, Danijel, Denzinger, Stefan, Burger, Maximilian, Hartmann, Arndt, Otto, Wolfgang, Breyer, Johannes, Wirtz, Ralph M., Erben, Philipp, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Sikic, Danijel, Burger, Maximilian, Hartmann, Arndt and Otto, Wolfgang (2018) High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma. Clinical Genitourinary Cancer 16 (4), 248-256.e2. Fulltext not available.

Breyer, Johannes, Wirtz, Ralph M., Otto, Wolfgang, Erben, Philipp, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Denzinger, Stefan, Burger, Maximilian and Hartmann, Arndt (2018) High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients. Cancer Immunology, Immunotherapy 67 (3), pp. 403-412. Fulltext not available.

2017

Sikic, Danijel, Breyer, Johannes, Hartmann, Arndt, Burger, Maximilian, Erben, Philipp, Denzinger, Stefan, Eckstein, Markus, Stöhr, Robert, Wach, Sven, Wullich, Bernd, Keck, Bastian, Wirtz, Ralph M. and Otto, Wolfgang (2017) High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer. Translational Oncology 10 (3), pp. 340-345. Fulltext not available.

Breyer, Johannes, Wirtz, Ralph M., Otto, Wolfgang, Erben, Philipp, Kriegmair, Maximilian C., Stoehr, Robert, Eckstein, Markus, Eidt, Sebastian, Denzinger, Stefan, Burger, Maximilian and Hartmann, Arndt (2017) In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival. Virchows Archiv 470 (3), pp. 267-274. Fulltext not available.

2016

Breyer, Johannes, Otto, Wolfgang, Wirtz, Ralph M., Wullich, Bernd, Keck, Bastian, Erben, Philipp, Kriegmair, Maximilian C. , Stoehr, Robert, Eckstein, Markus, Laible, Mark, Schlombs, Kornelia, Eidt, Sebastian, Denzinger, Stefan, Burger, Maximilian and Hartmann, Arndt (2016) ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ. Urologia Internationalis 98 (3), pp. 282-289. Fulltext not available.

Breyer, Johannes, Wirtz, Ralph M., Laible, Mark, Schlombs, Kornelia, Erben, Philipp, Kriegmair, Maximilian Christian, Stoehr, Robert, Eidt, Sebastian, Denzinger, Stefan, Burger, Maximilian, Hartmann, Arndt and Otto, Wolfgang (2016) ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC). Virchows Archiv 469 (5), pp. 547-552. Fulltext not available.

2015

Benderska, Natalya, Dittrich, Anna-Lena, Knaup, Sabine, Rau, Tilman T., Neufert, Clemens, Wach, Sven, Fahlbusch, Fabian B. , Rauh, Manfred, Wirtz, Ralph M., Agaimy, Abbas, Srinivasan, Swetha , Mahadevan, Vijayalakshmi, Rümmele, Petra, Rapti, Emmanouela, Gazouli, Maria, Hartmann, Arndt and Schneider-Stock, Regine (2015) miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis. Inflammatory Bowel Diseases 21 (9), pp. 2039-2051. Fulltext not available.

2013

Chakilam, Saritha, Gandesiri, Muktheshwar, Rau, Tilman T., Agaimy, Abbas, Vijayalakshmi, Mahadevan, Ivanovska, Jelena, Wirtz, Ralph M., Schulze-Luehrmann, Jan, Benderska, Natalya, Wittkopf, Nadine, Chellappan, Ajithavalli, Ruemmele, Petra, Vieth, Michael, Rave-Fränk, Margret, Christiansen, Hans, Hartmann, Arndt, Neufert, Clemens, Atreya, Raja, Becker, Christoph, Steinberg, Pablo and Schneider-Stock, Regine (2013) RETRACTED: Death-Associated Protein Kinase Controls STAT3 Activity in Intestinal Epithelial Cells. The American Journal of Pathology 182 (3), pp. 1005-1020. Fulltext not available.

This list was generated on Sat Apr 18 09:30:06 2026 CEST.
nach oben